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Abstract: 37 
Background: The high prevalence of cardiovascular disease (CVD) globally is attributable to an 38 
interaction between environmental and genetic factors. Gene × diet interaction studies aim to explore 39 
how a modifiable factor interacts with genetic predispositions. Here we have explored the interaction 40 
of a heat shock protein (HSP70) gene polymorphism (+1267A>G) with dietary intake and their 41 
possible association with serum C-reactive protein (CRP), an inflammatory marker, that is a major 42 
component of CVD risk. 43 
Methods: HSP70 genotype was determined using a TaqMan real time PCR based method. Genetic 44 
variation of the HSP70 gene +1267A>G locus. Dietary intake was assessed using a dietary 45 
questionnaire. Serum high sensitivity (Hs) CRP and other cardiovascular risk factors were assessed 46 
by routine methods. This included coronary angioplasty to determine the presence of coronary artery 47 
stenosis.  48 
Results: There were significant differences between serum lipid profile and Hs-CRP across the 49 
genotypes for Hsp70. The carriers of G allele had higher serum hs-CRP concentrations, compared 50 
with the AA homozygotes, with the wild genotype. Interaction analysis showed the association was 51 
modulated by total energy intake; the interaction of high energy intake with GG genotype: RERI= 52 
0.77, AP= 0.26, S=1.6. 53 
Conclusion: We have found a significant association between the +1267A>G variant of the HSP70 54 
gene with cardiovascular risk factors and serum hs-CRP concentrations. It is possible that a low 55 
energy diet could ameliorate the unfavorable effects of G allele of HSP70.  56 
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 60 
Introduction 61 
The heat shock proteins (HSPs) are a family of molecules that are released by cells in response to cell 62 
stress, that include: free radicals, sheer stress and toxins (1). Hsp70 has been shown to be highly 63 
expressed in different  physiological and environmental stress, and protects cell and tissues (2). There 64 
are, three human genes encoding members of HSP70 class including HSP70-1/2 and HSP70-hom (3) 65 
and this locus appears to be involved in determining CAD risk(4-6). 66 
We have previously reported an association between the HSP70-2 gene +1267A>G polymorphism 67 
with cardiovascular disease (7) and also with obesity as an important risk factor for cardiovascular 68 
disease (8). There have been other reports of a relationship between the 1267A>G Hsp70 variant with 69 
CVD risk factors (9, 10). These studies have evaluated the role of HSP70 gene variants on serum 70 
inflammatory biomarkers such as Hs-CRP (5, 10). Serum CRP, is an well established inflammatory 71 
marker that is related with an increased CVD risk (11). It is also possible that genetic predisposition 72 
and dietary factors interact to play an important role in determining CVD (12). 73 
We have therefore evaluated the association of a genetic variant, HSP70-2 gene +1267A>G with the 74 
presence of CAD , comparing CAD patients with 740 healthy individuals recruited from the Mashhad 75 
Stroke and Heart Atherosclerotic Disorders (MASHAD) cohort. Moreover, to test our hypothesis that 76 
this HSP70-2 +1267A>G may be associated with CAD and CRP, we examined the interaction of this 77 
genetic variant with dietary calories on serum hsCRP.   78 
 79 
Materials and methods 80 
Study population 81 
740 CAD patients undergoing coronary angiography with obstructive coronary artery disease (43% 82 
male, aged 49±8 years) were recruited from Ghaem Hospital. Written consent was obtained from all 83 
the participants. This research was approved by the Ethics Committee of the MUMS. 84 
Anthropometric and biochemical determination 85 
Anthropometric determinants, including height, body weight, waist and hip circumference were 86 
assessed (13). Biochemical parameters, including C-reactive protein (CRP), total cholesterol (TC), 87 
low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and 88 
triglyceride (TG), fasting blood glucose (FBG) were evaluated as described previously (14). 89 
Assessment of dietary intake 90 
A 24-h recall questionnaire was  used to assess daily intake, and this was analyzed as described 91 
previously (15) using Dietplan6 software (Forest field Software Ltd., UK).  92 
Genotyping  93 
The DNA was extracted using QIAamp- DNA Mini-Kit (Qiagen, San Diego, CA) based on the 94 
manufacturer’s instructions. To assess the concentration and purity of DNA, NanoDrop-1000-95 
Detector (NanoDrop-Technologies, Wilmington, USA) was used. Genotyping was carried out using 96 
Taqman-probes-based method with ~20 ng of DNA in TaqMan-Universal Master Mix with specific 97 
primers and probes (Applied Biosystems Foster City, CA). The ABIPRISM-7500 device equipped 98 
with the SDS software (version-2.0) was applied for determination of the allelic content of the 99 
samples (16, 17). 100 
Statistical analyses 101 
Data analysis was undertaken using SPSS 22 software (SPSS Inc, Chicago, IL). The Kolmogorov–102 
Smirnov test was utilized for evaluation of the normality of the variables within groups. Categorical  103 
data were assessed using a χ2 test. The statistical difference for genotype distribution and allele 104 
frequencies among groups was assessed by the χ2 analysis and Hardy-Weinberg equilibrium using a 105 
Pearson chi-square test. Differences between groups were investigated by ANOVA and t tests, or 106 
Kruskal–Wallis and Mann–Wilcoxon U tests. Residual models were used to adjust dietary intake 107 
variables for energy intake (18).We also examined multiplicative and additive interactions between 108 
the SNP and environmental factors (i.e. dietary intake) on the risk of high serum Hs-CRP 109 
concentrations. Multiplicative interaction was analyzed using the multiplicative term in a multiple 110 
logistic regression model. To examine the modifying influence of the studied variant on dietary intake 111 
in association with Hs-CRP concentration, we used multivariate logistic regression models. Potential 112 
confounders were adjusted for; these included: age, sex, physical activity, smocking, energy intake, 113 
body mass index and inflammatory markers, and white blood cell count (WBCC).  The main indices 114 
of biological interaction: AP, the attributable proportion due to interaction; RERI, the relative excess 115 
risk due to interaction; and S, the synergy index (19) were computed and calculated using the method 116 
of Andersson et al.(20). All the analyses were done using SPSS 20 (SPSS Inc., IL, USA) and a two-117 
sided statistical significance was set at P value ≤0.05.  118 
Results 119 
Association of HSP70-2 gene +1267A>G genetic variant with general characteristics of population 120 
The association of the HSP70-2 variant with demographic characteristics, fasted lipid profile, blood 121 
pressure, Inflammatory biomarkers and dietary Intake are shown in Table 1. The genotype 122 
distribution  of the polymorphism was in HWE (P>0.05). The frequency of the risk-associated G 123 
allele was 47.53 %, and the frequencies of AA, AG, and GG genotypes were respectively 18.7%, 124 
67.6% and 13.7%, in the total sample. There was no significant differences between different 125 
genotypes with respect to: weight, waist circumference and physical activity level (p value>0.05). 126 
However the sex distribution and age were significantly different. There were no significant 127 
differences between serum TG in different genotypes in different models (p value>0.05).  However 128 
serum cholesterol [p value (in recessive model) = 0.05), LDL [p value( in codominant model) = 129 
<0.001; p value (in recessive model) <0.001)], HDL [p value (in codominant model) = <0.001; p 130 
value (in recessive model) <0.001)] and FBS [p value (in additive model) = 0.05) were statistically 131 
different in subjects with different genotypes. Subjects who were homozygous for the G variant (GG 132 
genotype) also had higher DBP than CC genotypes however there was no significant difference 133 
between genotypes and SBP. Individuals who carried the GG genotype had higher serum HSP70 [p 134 
value (in recessive model) = 0.05] with higher serum Hs-CRP [p value (in recessive model) = 0.04], 135 
however there was no association with WBCC across different genotypes. 136 
Association of HSP70-2 gene +1267A>G genetic variant with serum Hs-CRP  137 
As shown in Table 2, after adjustment for the potential confounders, the HSP70-2 gene +1267A/G 138 
variant was associated with an increased likelihood of a high serum Hs-CRP concentration. We found 139 
a gene-disease association with an OR of 1.24 with an accuracy of >80% under the dominant genetic 140 
model with CRP. Therefore, subjects with GG genotype had a higher likelihood of a high CRP level 141 
(in adjusted dominant model, OR= 1.1, 95%CI (0.7-1.8), than those with the A allele.   142 
Interaction of life style with HSP70-2 gene +1267A> on and energy intake with serum Hs- CRP 143 
under dominant genetic model  144 
We also studied the nutrient intake across this genetic variant to determine the modulatory influence 145 
of diet on the outcome. We observed no statistically significant difference in dietary habit between 146 
groups in relation to macronutrients and energy consumption (Table 1). Interaction between gene × 147 
diet intakes was conducted on multiplicative and biological interaction analysis (Table 3 and figure 148 
1). There was no statistically significant multiplicative interaction (p value=0.5). However, results 149 
suggested an additive interaction between this variant with energy intake. These data showed that 150 
subjects with a GG genotype and high energy intake had an increased likelihood of a high serum Hs-151 
CRP (OR=3, 95%CI 1.2-7, p=0.01) compared with the reference group, defined as subjects with low 152 
risk; low energy intake and carrying A protective allele. The influence of both exposures together 153 
exceeds the effect of the two exposures separately and there was a positive and significant additive 154 
interaction. The parameters of additive interaction were also reported: RERI= 0.77, 95%CI: (-1.2-155 
2.8); AP=0.26, 95%CI: (-0.4-0.9) and SI=1.6, 95%CI: (0.3-8.6). A super additive interaction or 156 
positive interaction is said to exist when; RERI >0, AP >0, or S >1 (21). 157 
 158 
Discussion 159 
We have demonstrated that CAD patients with GG genotype and a high energy intake had an 160 
increased likelihood of a high serum Hs-CRP (OR=3, 95%CI 1.2-7, p=0.01), compared to the 161 
reference group that was defined based on subjects with less risk; low energy intake and carrying A 162 
protective allele. Moreover, we found that this effect was more pronounced when both factors were 163 
present, and there was a positive and significant additive interaction. This is consistent with previous 164 
observations on the role of this genetic marker with CAD, although our data is the first study showing 165 
a novel role of this genetic variant in interaction with life style as a susceptible predisposition marker 166 
in predicting the risk of CVD. Moreover, our data showed that subjects who carried a G allele  had 167 
higher serum cholesterol, LDL, TG/HDL. Although atherogenesis is a complex disorder, it is 168 
suggested that abnormalities in lipoprotein metabolism are one of the central factors. Lipid 169 
concentrations are important measures of cardiovascular disease risk, however several lipoprotein 170 
ratios or “atherogenic indices” have been defined to improve the predictive capability of the lipid 171 
profile. Dobiasova et al. found that Log (TG/HDL-C) had an association with the LDL-C particle 172 
diameter , and it has been proposed as an atherogenic index of plasma (AIP) which is indirect 173 
measure of the diameter of LDL-C particle(22).  The current study also showed that Hsp70-2 174 
polymorphism may affect hsCRP levels as a marker of inflammation. This supports our previous 175 
findings in which we demonstrated a higher prevalence of CAD and obesity as chronic inflammatory 176 
disease in subjects with G allele of HSP70-2 gene +1267ANG variant. Similarly, Hrira et.al have 177 
reported a positive correlation between P2–Hsp70-2 homozygous, higher level of hsCRP, LDL 178 
cholesterol, and the presence of CVD (5). The study of Nakhjavani  et.al in diabetic patients showed a 179 
direct correlation between asymmetric dimethylarginine (ADMA) and serum HSP70 with high serum 180 
hs-CRP in type 2 diabetes suggested that both ADMA and HSP70 play an inhibitory role on nitric 181 
oxide synthase (NOS) in inflammatory conditions (23). Consistent with these observations, Giacconi 182 
et.al, showed the association of Hsp70 1267 A/G SNP with pro-inflammatory cytokine production in 183 
healthy elderly and proposed this biomarker as a possible determinant of individual susceptibility to 184 
chronic diseases (24). Emerging evidence has shown that hsCRP and Hsp70 are biomarkers of 185 
increased risk of several chronic diseases; however, little is known about the function of these two 186 
biomarkers in combination and with the other inflammatory markers.(25-27).  187 
 188 
(9).  189 
We did not observe a relationship between the HSP-70 polymorphism and serum HSP-70 level in our 190 
study. This is consistent with the study of Contreras-Sesvold et.al, who also reported no significant 191 
differences for HSP70 concentrations across genotypes (28). Similarly, another study also examined 192 
the association of heat shock protein with different related polymorphisms (HSPA1B (2074G/C and 193 
1267A/G). They showed no differences in the serum HSP70 related to HSP70 gene polymorphism for 194 
HSPA1B gene locus 1267A/G (29). However, Gombos et.al has reported an interaction between the 195 
HspA1B +1267 allele G and Hsp70 concentrations (9). These contradictory data can be explained at 196 
least in part by sample size, different method of genotyping or expression  level analysis, ethnicity, 197 
etc.  198 
Inﬂammation is an important risk factor of CVD (30), and the onset and progress of an atherosclerotic 199 
lesion. The inﬂammatory response may be modulated by changes in dietary intake through both pro- 200 
and anti inﬂammatory pathways (31) . It has been shown that genetic alterations can inﬂuence the 201 
modulatory effect of diet on inflammation status. Therefore, we have investigated whether the 202 
magnitude of association between this variant was modulated by diet intake. Our results show that 203 
GG carriers for the HSP70-2 gene +1267ANG polymorphism with a high consumption of energy 204 
have a higher serum Hs-CRP concentration compared with the control subjects. Adiponectin is a 205 
well-known anti-inﬂammatory biomarker due to its suppression of TNF-alpha and adhesion 206 
molecules. Martinez et.al, reported in men with C/C homozygous of -11377 C > G at adipoQ were 207 
less insulin resistant by following a diet rich of MUFA and carbohydrate  in compared with the diet 208 
high in SFA(32-33).Another study by Song et.al demonstrated that the IL6R Asp358Ala (T/G) would 209 
interact with energy intake and obesity in Japanese population(34).  210 
In conclusion, we found that a genetic variant at the HSP70-2 gene locus (the +1267ANG) appears to 211 
be a factor in the inter-individual differences in the inflammation response that is modulated by a 212 
high energy diets in CAD patients. Our results suggest that a energy dense diet may exaserbate the 213 
inflammation status in CAD patient who carries risk genotype. Further studies are required to identify 214 
individuals who may benefit from a more personalized approach to diet modification. 215 
 216 
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Table 1. General characteristics of study population 309 
 310 
 311 
 312 
 313 
 314 
 315 
 316 
 317 
 318 
 319 
                                                           320 
# Additive genetic model (AA genotype vs. GG genotype); Recessive genetic model (AA genotype vs. GG/AG genotype).  321 
Abbreviation:  NS: Not Significant, PAL, physical activity level; WC, Waist circumference; SBP, Systolic blood pressure; 322 
DBP, Diastolic blood pressure; LDL, Low density lipoprotein; HDL, high density lipoprotein; HSP, Heat shock protein; 323 
Hscrp, high sensitive CRP; WBC, white blood cell. 324 
 325 
 326 
 327 
 328 
 329 
 330 
 331 
Variable 
Genotype 
P-value in genetic models 
Additive Recessive 
AA AG GG 
Demographic characteristics 
Age (y) 51.7±8.1 48.3±8 48.9±7.9 <0.001 <0.001 
Weight (kg) 71.8±11 73.8±13 73.5±10.8 NS NS 
Height (m) 1.6±0.09 1.61±0.09 1.57±0.09 0.04 NS 
WC (cm) 92.8±11 93.8±13 94.7±13.4 NS NS 
PAL 1.66±0.3 1.67±0.3 1.68±0.3 NS NS 
Lipid Profile/ Serum Glucose 
TG (mg/dl) 145±76 136±74 153±105 NS NS 
LDL (mg/dl) 115.3±38 96.7±35 101.5±41 <0.001 <0.001 
Cholesterol (mg/dl) 195.4±41 191.5±37.8 200±38 NS 0.05 
HDL (mg/dl) 43.7±10 49.6±11.6 49.4±11 <0.001 <0.001 
Cholesterol/LDL 4.6±1 4±1 4.3±1.3 <0.001 0.001 
TG/HDL 3.6±2.3 3±1.9 3.4±3 0.005 NS 
FBS (mg/dl) 96±37.6 92.4±30 100.7±41 NS NS 
Blood pressure 
DBP (mmHg) 83±12 79.9±10 81.4±10 0.052 NS 
SBP (mmHg) 127.8±21 123.9±20 126±20 NS NS 
Inflammatory biomarkers 
HSP70 (ng/ml) 4.3±6 5±8.6 4.2±7 NS 0.07 
HS-CRP (mg/l) 5.3±11 6.6±12 7.3±11 0.05 0.04 
WBC (×109/L)  6±1.6 6±1.5 5.8±1.3 NS NS 
Dietary Intake 
Energy (kcal) 1803±650 1731±624 1681±593 NS NS 
Fat (g) 73.6±23 75±17 75.7±17 NS NS 
Carbohydrate (g)  237±58 225.2±48 230.9±52 NS NS 
Protein (g) 66±18.6 72.7±27 65.5±18.5 NS NS 
 332 
 333 
Table 2. Association of HSP70-2 gene +1267A>G variant with serum Hs-CRP in Iranian under different 
genetic models. 
Risk allele Genetic Model Genotype 
N (%) 
Crude                    
OR* (95% CI) 
Adjusted  
OR* (95% CI) Case (n=342) 
Control 
(n=343) 
G Co-dominant AA 52 65 1  
 AG 216 208 1.26 (0.8-1.9) 1.24 (0.8-1.9) 
 GG 46 40 1.3 (0.7-2.3) 1.26 (0.7-2.2) 
Recessive    1.27 (0.8-1.9) 1.24 (0.86-1.9) 
Dominant    1.1 (0.7-1.7) 1.1 (0.7-1.8) 
Additive    1.1 (0.7-2.1) 1.4 (0.8-2.4) 
*Adjusted for age, sex, BMI, smoking, WBC. 334 
P value for dominant model=0.08 335 
Abbreviations: Hs-CRP; high sensitive CRP. 336 
Table 3. Interaction of HSP70-2 gene +1267A>G  gene and energy intake with serum Hs- CRP under dominant genetic model (n=463). 
 
Genotype distribution Interaction parameters 
AA/AG GG 
Multiplicative 
interaction 
 
Additive interaction measures 
Energy 
intake 
OR (95%CI) p value OR (95%CI) p value P value 
 
RERI AP SI 
low 1 
 
1.06 (0.4-2.5) 0.8 
0.5  0.77(-1.2-2.8) 0.26(-0.4-0.9) 1.6(0.3-8.6) 
high 2.1 (0.78-5.8) 0.1 3 (1.2-7) 0.01   
Adjusted for age, sex, BMI, smoking, WBC  
Dietary energy intake: high and low were above and below the median in the control group. 
Measures of biological interaction: RERI, the relative excess risk due to interaction; AP, the attributable proportion due to interaction; and S, the synergy index  
Statistically signiﬁcant with the 95% CI of RERI > 0, the 95% CI of AP > 0, or the 95% CI of S > 1, indicating positive additive interaction. 
 
